SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1860 7179 "

Sökning: L773:1860 7179

  • Resultat 1-10 av 39
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Borhade, Sanjay R., et al. (författare)
  • Preclinical Characterization of Acyl Sulfonimidamides : Potential Carboxylic Acid Bioisosteres with Tunable Properties
  • 2015
  • Ingår i: ChemMedChem. - : Wiley. - 1860-7179 .- 1860-7187. ; 10:3, s. 455-460
  • Tidskriftsartikel (refereegranskat)abstract
    • Herein we present the preclinical characterization of novel compounds containing the linear acyl sulfonimidamide functionality. Specifically, we studied the pK(a), lipophilicity, in vitro metabolic stability, plasma protein binding, Caco-2 permeability, and aqueous solubility for nine aryl acyl sulfonimidamides. In comparison with widely used carboxylic acid bioisosteres, the acyl sulfonimidamides were found to be less acidic and more lipophilic depending on the substitution pattern in the studied compounds. Importantly, the pKa values (5.9-7.6) were significantly influenced by substituents on the nitrogen atom and the aryl substituents. Moreover, the acyl sulfonimidamides displayed membrane permeabilities ranging from moderate to very high, which correlated with decreased pKa and low to negligible efflux ratios. We foresee that the chiral sulfur center and the two handles for structural diversity of linear acyl sulfonimidamides will offer new opportunities for drug design and for improving the oral bioavailability of acidic drug candidates.
  •  
2.
  • Bozzola, Tiago, et al. (författare)
  • Sialic Acid 4-N-Piperazine and Piperidine Derivatives Bind with High Affinity to the P. mirabilis Sialic Acid Sodium Solute Symporter
  • 2022
  • Ingår i: ChemMedChem. - : Wiley. - 1860-7179 .- 1860-7187. ; 17:23
  • Tidskriftsartikel (refereegranskat)abstract
    • In search for novel antibacterial compounds, bacterial sialic acid uptake inhibition represents a promising strategy. Sialic acid plays a critical role for growth and colonisation of several pathogenic bacteria, and its uptake inhibition in bacteria was recently demonstrated to be a viable strategy by targeting the SiaT sodium solute symporters from Proteus mirabilis and Staphylococcus aureus. Here we report the design, synthesis and evaluation of potential sialic acid uptake inhibitors bearing 4-N-piperidine and piperazine moieties. The 4-N-derivatives were obtained via 4-N-functionalization with piperidine and piperazine nucleophiles in an efficient direct substitution of the 4-O-acetate of Neu5Ac. Evaluation for binding to bacterial transport proteins with nanoDSF and ITC revealed compounds possessing nanomolar affinity for the P. mirabilis SiaT symporter. Computational analyses indicate the engagement of a previously untargeted portion of the binding site.
  •  
3.
  • Briggner, Lars-Erik, et al. (författare)
  • In Silico Solid State Perturbation for Solubility Improvement
  • 2014
  • Ingår i: ChemMedChem. - : Wiley. - 1860-7179 .- 1860-7187. ; 9:4, s. 724-726
  • Tidskriftsartikel (refereegranskat)abstract
    • Solubility is a frequently recurring issue within pharmaceutical industry, and new methods to proactively resolve this are of fundamental importance. Here, a novel methodology is reported for intrinsic solubility improvement, using insilico prediction of crystal structures, by perturbing key interactions in the crystalline solid state. The methodology was evaluated with a set of benzodiazepine molecules, using the two-dimensional molecular structure as the only a priori input. The overall trend in intrinsic solubility was correctly predicted for the entire set of benzodiazepines molecules. The results also indicate that, in drug compound series where the melting point is relatively high (i.e., brick dust compounds), the reported methodology should be very suitable for identifying strategically important molecular substitutions to improve solubility. As such, this approach could be a useful predictive tool for rational compound design in the early stages of drug development.
  •  
4.
  • Di, Li, et al. (författare)
  • The Critical Role of Passive Permeability in Designing Successful Drugs
  • 2020
  • Ingår i: ChemMedChem. - : Wiley. - 1860-7179 .- 1860-7187. ; 15:20, s. 1862-1874
  • Forskningsöversikt (refereegranskat)abstract
    • Passive permeability is a key property in drug disposition and delivery. It is critical for gastrointestinal absorption, brain penetration, renal reabsorption, defining clearance mechanisms and drug-drug interactions. Passive diffusion rate is translatable across tissues and animal species, while the extent of absorption is dependent on drug properties, as well as in vivo physiology/pathophysiology. Design principles have been developed to guide medicinal chemistry to enhance absorption, which combine the balance of aqueous solubility, permeability and the sometimes unfavorable compound characteristic demanded by the target. Permeability assays have been implemented that enable rapid development of structure-permeability relationships for absorption improvement. Future advances in assay development to reduce nonspecific binding and improve mass balance will enable more accurately measurement of passive permeability. Design principles that integrate potency, selectivity, passive permeability and other ADMET properties facilitate rapid advancement of successful drug candidates to patients.
  •  
5.
  • Diaz-Holguin, Alejandro, et al. (författare)
  • When Two Become One : Conformational Changes in FXR/RXR Heterodimers Bound to Steroidal Antagonists
  • 2023
  • Ingår i: ChemMedChem. - : John Wiley & Sons. - 1860-7179 .- 1860-7187. ; 18:4
  • Tidskriftsartikel (refereegranskat)abstract
    • Farnesoid X receptor (FXR) is a nuclear receptor with an essential role in regulating bile acid synthesis and cholesterol homeostasis. FXR activation by agonists is explained by an alpha AF-2-trapping mechanism; however, antagonism mechanisms are diverse. We discuss microsecond molecular dynamics (MD) simulations investigating our recently reported FXR antagonists 2a and 2 h. We study the antagonist-induced conformational changes in the FXR ligand-binding domain, when compared to the synthetic (GW4064) or steroidal (chenodeoxycholic acid, CDCA) FXR agonists in the FXR monomer or FXR/RXR heterodimer r, and in the presence and absence of the coactivator. Our MD data suggest ligand-specific influence on conformations of different FXR-LBD regions, including the alpha 5/alpha 6 region, alpha AF-2, and alpha 9-11. Changes in the heterodimerization interface induced by antagonists seem to be associated with alpha AF-2 destabilization, which prevents both co-activator and co-repressor recruitment. Our results provide new insights into the conformational behaviour of FXR, suggesting that FXR antagonism/agonism shift requires a deeper assessment than originally proposed by crystal structures.
  •  
6.
  • Erdelyi, Mate, 1975, et al. (författare)
  • The Binding Mode of Side Chain- and C3-Modified Epothilones to Tubulin
  • 2010
  • Ingår i: ChemMedChem. - : Wiley. - 1860-7179 .- 1860-7187. ; 5:6, s. 911-920
  • Tidskriftsartikel (refereegranskat)abstract
    • The tubulin-binding mode of C3- and C15-modified analogues of epothilone A (Epo A) was determined by NMR spectroscopy and computational methods and compared with the existing structural models of tubulin-bound natural Epo A. Only minor differences were observed in the conformation of the macrocycle between Epo A and the C3-modified analogues investigated. In particular, 3-deoxy- (compound 2) and 3-deoxy-2,3-didehydro-Epo A (3) were found to adopt similar conformations in the tubulin-binding cleft as Epo A, thus indicating that the 3-OH group is not essential for epothilones to assume their bioactive conformation. None of the available models of the tubulin-epothilone complex is able to fully recapitulate the differences in tubulin-polymerizing activity and microtubule-binding affinity between C20-modified epothilones 6 (C20-propyl), 7 (C20-butyl), and 8 (C20-hydroxypropyl). Based on the results of transferred NOE experiments in the presence of tubulin, the isomeric C15 quinoline-based Epo B analogues 4 and 5 show very similar orientations of the side chain, irrespective of the position of the nitrogen atom in the quinoline ring. The quinoline side chain stacks on the imidazole moiety of -His227 with equal efficiency in both cases, thus suggesting that the aromatic side chain moiety in epothilones contributes to tubulin binding through strong van der Waals interactions with the protein rather than hydrogen bonding involving the heteroaromatic nitrogen atom. These conclusions are in line with existing tubulin polymerization and microtubule-binding data for 4, 5, and Epo B.
  •  
7.
  •  
8.
  • Friedman, Ran, et al. (författare)
  • Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring
  • 2009
  • Ingår i: ChemMedChem. - : Wiley. - 1860-7179 .- 1860-7187. ; 4:8, s. 1317-1326
  • Tidskriftsartikel (refereegranskat)abstract
    • Plasmepsins (PMs) are essential proteases of the plasmodia parasites and are therefore promising targets for developing drugs against malaria. We have discovered six inhibitors of PM II by high-throughput fragment-based docking of a diversity set of ∼40 000 molecules, and consensus scoring with force field energy functions. Using the common scaffold of the three most active inhibitors (IC50=2–5 μM), another seven inhibitors were identified by substructure search. Furthermore, these 13 inhibitors belong to at least three different classes of compounds. The in silico approach was very effective since a total of 13 active compounds were discovered by testing only 59 molecules in an enzymatic assay. This hit rate is about one to two orders of magnitude higher than those reported for medium- and high-throughput screening techniques in vitro. Interestingly, one of the inhibitors identified by docking was halofantrine, an antimalarial drug of unknown mechanism. Explicit water molecular dynamics simulations were used to discriminate between two putative binding modes of halofantrine in PM II.
  •  
9.
  • Fritzson, Ingela, et al. (författare)
  • Inhibition of Human DHODH by 4-Hydroxycoumarins, Fenamic Acids, and N-(Alkylcarbonyl)anthranilic Acids Identified by Structure-Guided Fragment Selection
  • 2010
  • Ingår i: ChemMedChem. - : Wiley. - 1860-7187 .- 1860-7179. ; 5:4, s. 608-617
  • Tidskriftsartikel (refereegranskat)abstract
    • A strategy that combines virtual screening and structureguided selection of fragments was used to identify three unexplored classes of human DHODH inhibitor compounds: 4-hydroxycoumarins, fenamic acids, and N-(alkylcarbonyl)anthranilic acids. Structure-guided selection of fragments targeting the inner subsite of the DHODH ubiquinone binding site made these findings possible with screening of fewer than 300 fragments in a DHODH assay. Fragments from the three inhibitor classes identified were subsequently chemically expanded to target an additional subsite of hydrophobic character. All three classes were found to exhibit distinct structure–activity relationships upon expansion. The novel N-(alkylcarbonyl anthranilic acid class shows the most promising potency against human DHODH, with IC50 values in the low nanomolar range. The structure of human DHODH in complex with an inhibitor of this class is presented.
  •  
10.
  • Gabel, Detlef, et al. (författare)
  • The Anionic Boron Cluster (B(12)H(11)SH)(2-) as a Means To Trigger Release of Liposome Contents.
  • 2007
  • Ingår i: ChemMedChed. - : Wiley. - 1860-7179. ; 2:1, s. 51-53
  • Tidskriftsartikel (refereegranskat)abstract
    • Triggered release. Liposomes are novel carriers for pharmaceutical agents and can be triggered to release their contents by the addition of B12H11SH, a compound in clinical use. As systemic toxicity is decreased relative to the free drug, liposomal drugs can therefore be administered in higher concentrations before dose-limiting side effects are met. Thus, liposome-encapsulated drugs may be of great value in the therapy of diseases.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 39
Typ av publikation
tidskriftsartikel (37)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (39)
Författare/redaktör
Leffler, Hakon (4)
Odell, Luke R (4)
Arvidsson, Per I. (3)
Robinson, Phillip J (3)
McCluskey, Adam (3)
Luthman, Kristina, 1 ... (3)
visa fler...
Chau, Ngoc (2)
Kloo, Lars (2)
Artursson, Per (2)
Erdelyi, Mate, 1975 (1)
Guo, J. (1)
Zhao, X. (1)
Ma, Y. (1)
Larsson, Rolf (1)
Håkansson, Maria (1)
Helleday, Thomas (1)
Mariana, Anna (1)
Nilsson, Ulf (1)
Walse, Björn (1)
Zhou, Q. (1)
Edwards, Katarina (1)
Karlsson, Göran (1)
Lennernäs, Hans (1)
Ellervik, Ulf (1)
Sharma, M. (1)
Brown, PJ (1)
Rojas-Macias, Miguel ... (1)
Almqvist, Fredrik (1)
Al-Karadaghi, Salam (1)
Fryknäs, Mårten (1)
Li, M. (1)
Loseva, Olga (1)
Friedman, Ran (1)
Brandt, Peter (1)
Norinder, Ulf (1)
Machado, M (1)
Wiita, E (1)
Xie, H (1)
Henriksson, M (1)
Svensson, Richard (1)
Lundbäck, Thomas (1)
Helleday, T (1)
Ryde, Ulf (1)
Govender, Thavendran (1)
Kruger, Hendrik G. (1)
Gertsch, J (1)
Andersson, C. David (1)
Schuler, H. (1)
Åqvist, Johan (1)
Maguire, Glenn E. M. (1)
visa färre...
Lärosäte
Uppsala universitet (17)
Lunds universitet (8)
Göteborgs universitet (7)
Karolinska Institutet (7)
Kungliga Tekniska Högskolan (5)
Stockholms universitet (4)
visa fler...
Umeå universitet (2)
Chalmers tekniska högskola (1)
Linnéuniversitetet (1)
RISE (1)
visa färre...
Språk
Engelska (39)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (21)
Naturvetenskap (20)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy